National NeuroHIV Tissue Consortium (NNTC) Clinical Sites

The National Institutes of Health National Institute on Drug Abuse seeks proposals to establish multiple clinical sites as part of the National NeuroHIV Tissue Consortium. Sites will be responsible for recruitment, longitudinal follow up care, data collection, and the acquisition, processing, storage, and distribution of central nervous system and related biospecimens from donors with and without HIV infection. Proposals will be evaluated based on acquisition capabilities and characteristics of donor specimens, NNTC clinical site characteristics including methods and infrastructure, and personnel qualifications. The deadline for questions is August 10, 2022 and proposals are due by October 14, 2022.

There is no set-aside designation. Multiple awards are anticipated for an estimated total value of $5-10 million over the five-year base period and four one-year option periods. Up to eight clinical sites may be selected to collect specimens and data annually according to metrics determined at award, with a performance period through February 2028. Sites will be located nationwide to provide specimens and data to researchers through the NNTC, which aims to advance neuroHIV research.